Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1598814

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1598814

Vaccine Vials Market by Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity, Application - Global Forecast 2025-2030

PUBLISHED:
PAGES: 190 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Vaccine Vials Market was valued at USD 629.96 million in 2023, expected to reach USD 697.72 million in 2024, and is projected to grow at a CAGR of 10.84%, to USD 1,295.47 million by 2030.

The vaccine vials market encompasses the production and distribution of small glass or plastic containers used to store vaccines. These vials are crucial for maintaining vaccine potency, ensuring safe and effective delivery, and accommodating storage logistics. The necessity of vaccine vials stems from their role in safeguarding vaccine potency, facilitating safe transportation, and delivering precise doses during vaccination processes. Their application spans across various end-use sectors, including hospitals, clinics, and research laboratories. Key growth drivers include the increasing prevalence of infectious diseases, ongoing vaccine development due to emerging health threats such as COVID-19, and robust immunization programs globally. Additionally, technological advancements in manufacturing processes, enabling safer and more efficient vial production, represent compelling opportunities. Collaborations with pharmaceutical companies for innovative packaging solutions can further strengthen market position. However, market growth faces challenges like stringent regulatory requirements, high manufacturing costs, and supply chain disruptions that could impede expansion. The rise in demand for sustainable packaging places pressure on manufacturers to innovate with eco-friendly materials, highlighting potential areas for research and development. Exploring biodegradable and recyclable materials, and improving the efficiency of the cold chain logistics, presents avenues for innovation. Moreover, there's an opportunity in the development of smart vials incorporating digital features, like temperature sensors, to enhance the integrity of vaccine storage. These innovations can potentially open new markets and enhance existing operations by addressing current market limitations and aligning with sustainability goals. Market dynamics indicate a competitive landscape where constant innovation is crucial for staying pertinent amid rapidly evolving public health needs. In conclusion, prioritizing research in sustainable packaging materials coupled with smart vial technology can provide long-term business growth while meeting the high-demand requirements and operational challenges faced in the pharmaceutical industry.

KEY MARKET STATISTICS
Base Year [2023] USD 629.96 million
Estimated Year [2024] USD 697.72 million
Forecast Year [2030] USD 1,295.47 million
CAGR (%) 10.84%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vials Market

The Vaccine Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of infectious diseases and demands for number of vaccines
    • Growing initiatives from government and private organizations to advance vaccination
  • Market Restraints
    • Lack of healthcare infrastructure
  • Market Opportunities
    • Rising preference for high performance packaging solutions
    • Increasing importance of vvm to ensure vaccine safety
  • Market Challenges
    • High-cost associated with the supply chain of vaccine vials

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vials Market

A detailed market share analysis in the Vaccine Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vials Market

A strategic analysis of the Vaccine Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vials Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Multi Dose and Single Dose.
  • Based on Material, market is studied across Glass and Polymer.
  • Based on Capacity, market is studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
  • Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-F74E250AD5FF

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of infectious diseases and demands for number of vaccines
      • 5.1.1.2. Growing initiatives from government and private organizations to advance vaccination
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of healthcare infrastructure
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preference for high performance packaging solutions
      • 5.1.3.2. Increasing importance of vvm to ensure vaccine safety
    • 5.1.4. Challenges
      • 5.1.4.1. High-cost associated with the supply chain of vaccine vials
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Vials Market, by Type

  • 6.1. Introduction
  • 6.2. Multi Dose
  • 6.3. Single Dose

7. Vaccine Vials Market, by Material

  • 7.1. Introduction
  • 7.2. Glass
  • 7.3. Polymer

8. Vaccine Vials Market, by Capacity

  • 8.1. Introduction
  • 8.2. 10ml
  • 8.3. 20ml
  • 8.4. 2ml
  • 8.5. 3ml
  • 8.6. 5ml

9. Vaccine Vials Market, by Application

  • 9.1. Introduction
  • 9.2. Preventive Vaccine
  • 9.3. Therapeutic Vaccine

10. Americas Vaccine Vials Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vaccine Vials Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vaccine Vials Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cardinal Health, Inc.
  • 2. Catalent, Inc.
  • 3. Corning Incorporated
  • 4. DWK Life Sciences GmbH
  • 5. Elitech Technology, Inc.
  • 6. ELPRO-BUCHS AG
  • 7. EVIGENCE SENSORS Inc.
  • 8. Gerresheimer AG
  • 9. Lisaline Lifescience Technologies Pvt Ltd.
  • 10. Nipro Corporation
  • 11. Pacific Vial Manufacturing Inc.
  • 12. Schott AG
  • 13. Stevanato Group
  • 14. Temptime Corporation by Zebra Technologies Corporation
  • 15. Thermo Fisher Scientific Inc.
Product Code: MRR-F74E250AD5FF

LIST OF FIGURES

  • FIGURE 1. VACCINE VIALS MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE VIALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE VIALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE VIALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE VIALS MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE VIALS MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE VIALS MARKET SIZE, BY POLYMER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VACCINE VIALS MARKET SIZE, BY 10ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VACCINE VIALS MARKET SIZE, BY 20ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VACCINE VIALS MARKET SIZE, BY 2ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VACCINE VIALS MARKET SIZE, BY 3ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VACCINE VIALS MARKET SIZE, BY 5ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA VACCINE VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM VACCINE VIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. VACCINE VIALS MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!